Orthobiologics Market, By Product Type (Bone Allograft, Machined Bones, Demineralized Bone Matrix, Synthetic Bone Substitutes, BMP, Stem Cell Therapy, Viscosupplementation), By Application (Spinal Fusion, Trauma, Reconstructive Surgeries), and By Region (

Orthobiologics Market, By Product Type (Bone Allograft, Machined Bones, Demineralized Bone Matrix, Synthetic Bone Substitutes, BMP, Stem Cell Therapy, Viscosupplementation), By Application (Spinal Fusion, Trauma, Reconstructive Surgeries), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Orthobiologics are substances used to heal injuries such as fractures and injured muscles, ligaments, and tendons within a short period of time. Orthobiologics are made from substances that naturally occur in the body. Some examples of orthobiologics are bone grafts, autologous blood, autologous conditioned serum, platelet rich plasma, growth factors, and stem cells. Increasing prevalence of injury and facture due to falls and road accidents along with increasing prevalence of chronic arthritis are expected to augment growth of the orthobiologics market
Key features of the study:
This report provides in-depth analysis of the Global Orthobiologics market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Orthobiologics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Zimmer Biomet Holdings, Inc., Bone Biologics Corp, Harvest Technologies Corporation, Globus Medical, Inc., Smith & Nephew plc, Stryker Corporation, Genzyme, Alphatec Spine, Inc., Bacterin International, Inc., DePuy Synthes, Inc. (A Johnson & Johnson Company), Exactech, Inc., Globus Medical, Inc., Integra LifeSciences Corporation, Medtronic, Plc, NuVasive, Inc., Orthofix Holdings, Inc., SeaSpine Holdings Corporation, and Ortho Regenerative Technologies Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Orthobiologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Orthobiologics market
Detailed Segmentation:
Global Orthobiologics Market, By Product Type:
Bone Allograft
Machined Bones
Demineralized Bone Matrix
Synthetic Bone Substitutes
BMP
Stem Cell Therapy
Viscosupplementation
Global Orthobiologics Market, By Application:
Spinal Fusion
Trauma
Reconstructive Surgeries
Global Orthobiologics Market, By Region:
North America
By Product Type:
Bone Allograft
Machined Bones
Demineralized Bone Matrix
Synthetic Bone Substitutes
BMP
Stem Cell Therapy
Viscosupplementation
By Application
Spinal Fusion
Trauma
Reconstructive Surgeries
By Country
U.S.
Canada
Latin America
By Product Type:
Bone Allograft
Machined Bones
Demineralized Bone Matrix
Synthetic Bone Substitutes
BMP
Stem Cell Therapy
Viscosupplementation
By Application
Spinal Fusion
Trauma
Reconstructive Surgeries
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Bone Allograft
Machined Bones
Demineralized Bone Matrix
Synthetic Bone Substitutes
BMP
Stem Cell Therapy
Viscosupplementation
By Application
Spinal Fusion
Trauma
Reconstructive Surgeries
By Country
U.K.
Germany
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
By Product Type:
Bone Allograft
Machined Bones
Demineralized Bone Matrix
Synthetic Bone Substitutes
BMP
Stem Cell Therapy
Viscosupplementation
By Application
Spinal Fusion
Trauma
Reconstructive Surgeries
By Country
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Bone Allograft
Machined Bones
Demineralized Bone Matrix
Synthetic Bone Substitutes
BMP
Stem Cell Therapy
Viscosupplementation
By Application
Spinal Fusion
Trauma
Reconstructive Surgeries
By Country
GCC Countries
Israel
Rest of Middle East
Africa
By Product Type:
Bone Allograft
Machined Bones
Demineralized Bone Matrix
Synthetic Bone Substitutes
BMP
Stem Cell Therapy
Viscosupplementation
By Application
Spinal Fusion
Trauma
Reconstructive Surgeries
By Country
North Africa
Central Africa
South Africa
Company Profiles
Zimmer Biomet Holdings, Inc. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Bone Biologics Corp
Harvest Technologies Corporation
Globus Medical, Inc.
Smith & Nephew plc
Stryker Corporation
Genzyme
Alphatec Spine, Inc.
Bacterin International, Inc.
DePuy Synthes, Inc. (A Johnson & Johnson Company)
Exactech, Inc.
Globus Medical, Inc.
Integra LifeSciences Corporation
Medtronic, Plc
NuVasive, Inc.
Orthofix Holdings Inc.
SeaSpine Holdings Corporation
Ortho Regenerative Technologies Inc.
“*” marked represents similar segmentation in other categories in the respective section.